Report
Kristoffer Inton
EUR 850.00 For Business Accounts Only

Morningstar | Initiating on Fast-Growing Cannabis Industry: We See Curaleaf as Undervalued

We are initiating coverage of cannabis, an industry we forecast to grow by 9 times through 2030 amid widening legalization and increased participation for the Canadian, international, and U.S. markets.

For Canada, despite recent recreational legalization, cannabis has penetrated just 12% of our estimated market, setting the stage for 20% CAGR through 2030.

For the international market, we forecast market potential of nearly $43 billion and 23% CAGR through 2030 as more and more countries recognize the benefits of medical cannabis. However, increasing competition from other countries could limit the opportunity for Canadian producers to $20 billion.

For the U.S., recreational and medicinal cannabis has penetrated just 8% and 21% of their estimated markets, leading to 25% CAGR and 15% CAGR through 2030, respectively. We expect six more states to legalize recreational cannabis and three states to expand commercial distribution. Furthermore, we expect the federal government will recognize states’ right to decide legality.

We are initiating coverage of Curaleaf Holdings, which cultivates and sells cannabis in the U.S. with a presence in 15 states. Our fair value estimates are $10.50 per share and CAD 14 per share, respectively. Our fair value estimates are based on a 10-year explicit forecast that assumes roughly 36% revenue CAGR and a 2028 operating margin before plant adjustments of 32%. We assign Curaleaf a no-moat rating and stable moat trend, as it will struggle to earn economic profit as it spends on growth in the early-stage industry.

At today’s price, we see shares as undervalued. Curaleaf offers the advantage of pure-play exposure to the U.S. through a vertically-integrated operation that includes cultivation, processing, and dispensary operations on the East and West Coasts. Unlike Curaleaf’s Canadian peers, it does not operate internationally, which is a disadvantage since the global market looks lucrative.


For more details on the cannabis industry and our market forecasts, please see our observer, “Green Rush: Cannabis Market Will Grow by 9 Times by 2030 Amid Widening Legalization.”
Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Kristoffer Inton

Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch